Healthcare management and administration service company Express Scripts is scheduled to report second-quarter results on Tuesday, July 28 after market close. With shares hitting all-time highs before ...
Express Scripts Holding Company (Nasdaq: ESRX) is a Nasdaq-100 company that believes "diversity and inclusion are the foundation on which success and growth are built." This company walks the talk, ...
PARIS--(BUSINESS WIRE)--Sofinnova Partners, a leading European life sciences venture capital firm based in Paris, London and Milan, announced today that its portfolio company DNA Script has raised ...
The recent offer from Cigna provides an excellent opportunity to buy Express Scripts with limited downside. Express Script's CEO is very long Express while Cigna's CEO is short Cigna. Express is ...
ST. LOUIS, Dec. 3 /PRNewswire-FirstCall/ -- Express Scripts (Nasdaq: ESRX) announced it has earned URAC accreditation for Workers' Compensation Pharmacy Benefit ...
Express Scripts Holding Company (NASDAQ:ESRX) — the largest pharmacy benefit manager, or PBM, in America — is also one of the most important companies in the health care industry. PBMs fill ...
Walgreen Company (NYSE:WAG) recently made mistakes that temporarily affected its stock in a negative way. Its greatest error was choosing to not participate in the ...
MannKind hire David Kendall as Chief Medical Officer. Afrezza scripts come in flat. Cash estimate at about $37 million. From an investment standpoint, the addition of Kendall is not something that ...
Analysts expect Express Scripts to report meaningful growth for both revenue and earnings for its second quarter. The average analyst estimate is for adjusted EPS and revenue of $1.40 and $26.15 ...
What investors need to know before Express Scripts reports second-quarter results. Expectations Analysts expect Express Scripts to report meaningful growth for both revenue and earnings for its second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback